The case involves Andreea Raducan, a 16-year-old Romanian gymnast who won gold in the Women’s Individual All-Around Event at the 2000 Sydney Olympics but was later disqualified after testing positive for pseudoephedrine, a prohibited substance. The substance was found in her urine sample at levels significantly above the IOC threshold, traced to Nurofen Cold and Flu tablets prescribed by her team doctor to treat a headache and congestion. Raducan did not declare the medication on her doping control form. The IOC Executive Board disqualified her, revoked her gold medal, and ordered its return. Raducan appealed to the Court of Arbitration for Sport (CAS), arguing discrepancies in the urine volume recorded during testing and claiming no intent to dope. The CAS panel rejected her arguments, upholding the principle of strict liability under the Olympic Movement Anti-Doping Code, which holds athletes responsible for any prohibited substances in their system, regardless of intent or competitive advantage. The panel emphasized that Raducan’s age and lack of intent did not exempt her from liability, as the rules apply uniformly to all athletes. The CAS confirmed the IOC’s decision, reinforcing the strict liability standard and the importance of athlete education and medical oversight to prevent unintentional violations. The ruling maintained the integrity of anti-doping efforts while acknowledging the unfortunate circumstances of Raducan’s case. The Panel also noted that the IOC had considered subjective elements and chose not to impose further sanctions, a decision the CAS found appropriate. The case underscores the balance between individual circumstances and the broader commitment to fair play and drug-free competition, concluding that the Anti-Doping Code must be enforced without exception to ensure fairness for all athletes. The CAS dismissed Raducan’s application and upheld the IOC’s decision, highlighting the unwavering commitment to anti-doping principles in sports.